Data / Form D filings / Prana Therapies, Inc.
Prana Therapies, Inc.: Form D filings
Prana Therapies, Inc., a biotechnology company in Encinitas, CA, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on August 10, 2026, reports $40.2 million sold of a $40.2 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 378 Neptune Avenue, Encinitas, CA, 92024
- Phone
- (858) 208-0193
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2029240
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | New notice | $40,226,932 | $40,226,932 | 9 | Nov 25, 2025 | sec.gov | |
| Jul 19, 2024 | New notice | $9,000,000 | $5,000,000 | $4,000,000 | 2 | May 30, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ben Auspitz | Director | |
| Alexis Borisy | Director | |
| Sheila Gujrathi, M.D. | Executive Officer, Director | |
| Hector Ortega | Executive Officer | |
| Ryan Sullivan | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 10, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Prana Therapies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.